These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3168476)

  • 1. The picture of hypertrophic cardiomyopathy in the elderly.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1988; 30(3):177-85. PubMed ID: 3168476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertrophic obstructive cardiomyopathy: surgical treatment and results].
    Schulte HD; Lösse B
    Herz; 1985 Apr; 10(2):102-11. PubMed ID: 4039290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical ASH)].
    Koga Y; Takahashi H; Ifuku M; Itaya M; Adachi K; Toshima H
    J Cardiogr; 1984 Aug; 14(2):301-10. PubMed ID: 6543446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertrophic cardiomyopathy. Correlation between the morphologic-quantitative data of the 2-dimensional echocardiogram and electro-vectorcardiographic aspects].
    De Piccoli B; Ciriello A; Trolese C; Franceschi M; Piccolo E
    G Ital Cardiol; 1986 Apr; 16(4):283-94. PubMed ID: 3743930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy with left ventricular dilatation].
    Iwami G; Miyazaki Y; Matsuyama K; Shida M; Ooga M; Furuta Y; Ikeda H; Toshima H; Chiba M; Koga Y
    J Cardiol; 1988 Jun; 18(2):319-28. PubMed ID: 3249261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between disorders of cardiac rhythm to the symptomatology and extent of hypertrophic cardiomyopathy].
    Gregor P; Widimský P; Kohout P; Sochor K; Bufka V; Cervenka V; Vísek V
    Vnitr Lek; 1989 Jul; 35(7):632-8. PubMed ID: 2800367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aortic regurgitation in hypertrophic cardiomyopathy as detected by color Doppler echocardiography].
    Shiota T; Sakamoto T; Amano K; Hada Y; Takenaka K; Hasegawa I; Takahashi T; Suzuki J; Takahashi H; Sugimoto T
    J Cardiol; 1987 Dec; 17(4):759-68. PubMed ID: 3506602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis of hypertrophic cardiomyopathy: echocardiographic and postmortem histopathologic study of 30 patients].
    Emoto R; Yokota Y; Miki T; Nomura H; Miki T; Usuki S; Chou HT; Kurozumi H; Seo T; Fukuzaki H
    J Cardiol; 1988 Sep; 18(3):695-703. PubMed ID: 3249285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advanced sequelae of apical hypertrophic cardiomyopathy: report of two cases with wall motion abnormalities].
    Kusukawa J; Suwa M; Nakayama Y; Hirota Y; Kawamura K; Adachi I; Akagi H
    J Cardiol; 1988 Mar; 18(1):259-69. PubMed ID: 3221316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mitral valve prolapse with myocardial disarrangement and familial hypertrophic cardiomyopathy: a case report].
    Kumaki T; Yokota Y; Okamoto K; Takarada A; Seo T; Maehashi N; Toyama S; Fukuzaki H
    J Cardiogr; 1986 Mar; 16(1):227-36. PubMed ID: 3782885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic heterogeneity in hypertrophic cardiomyopathy with regard to age, asymmetric septal hypertrophy, and concentric hypertrophy beyond the pediatric age group.
    Litovsky SH; Rose AG
    Arch Pathol Lab Med; 1998 May; 122(5):434-41. PubMed ID: 9593345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].
    Fattori R; Rapezzi C; Castriota F; Magnani G; Bertaccini P; Galiè N; Magnani B; Gavelli G
    Radiol Med; 1994; 88(1-2):36-43. PubMed ID: 8066253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertrophic cardiomyopathy: distribution of the hypertrophy evaluated by bidimensional echocardiography and observations on the genesis of the obstruction].
    Lazzeroni E; Domenicucci S; Das S; ten Cate F; Roelandt J
    G Ital Cardiol; 1984 Jun; 14(6):418-23. PubMed ID: 6541170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of regional contractile dynamics and pathological findings of the left ventricular wall in patients with hypertrophic cardiomyopathy].
    Usuki S; Yokota Y; Maehashi N; Nakanishi M; Nakanishi O; Emoto R; Kurozumi H; Miki T; Fukuzaki H; Ito H
    J Cardiol; 1988 Sep; 18(3):665-72. PubMed ID: 3249283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of electrocardiographic features and distribution of hypertrophy in hypertrophic non-obstructive cardiomyopathy during childhood].
    Kamiya Y; Oonaka M; Itoi T; Hamaoka K; Onouchi Z
    J Cardiol; 1994; 24(2):91-106. PubMed ID: 8164151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.